Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

July 2, 2021
BioUtah News Economic Developments Life Sciences Industry News Utah's Life Sciences Companies
Thermo Fisher Opening New Manufacturing Facility In Ogden

Thermo Fisher is opening a new facility at the Boyer Business Depot Ogden, hiring 450 employees by 2022. Ogden City announced the plans on Tuesday. “Thermo Fisher has had a presence in Utah for many years,” said Kelvyn Cullimore, president and CEO of BioUtah. “The company’s expansion in Ogden reflects their commitment to Utah jobs, […]

July 1, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
RECURSION ANNOUNCES MULTI-YEAR COLLABORATION WITH MILA FOR TECH-ENABLED DRUG DISCOVERY

Recursion has announced a multi-year collaboration with Mila, the Quebec Artificial Intelligence Institute, to accelerate Recursion’s machine learning capabilities. Recursion will open office space within Mila and build a team focused on using machine learning for tech-enabled drug discovery. “Recursion is executing at the forefront of multiple technical fields including biology, chemistry, automation, engineering and […]

July 1, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Epitel Publishes First Peer-Reviewed Research Paper

BioUtah congratulates the Epitel team on its first peer-reviewed manuscript, “Electrographic Seizure Monitoring with a Novel, Wireless, Single-Channel EEG Sensor,” comparing Epilog EEG to the clinical gold-standard of traditional EEG. The publication appears in Clinical Neurophysiology Practice. People living with epilepsy could benefit by having a more accurate and objective wearable EEG system for counting seizures […]

July 1, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
RenalytixAI’s KidneyIntelX™ Demonstrates Effectiveness In Monitoring Therapeutic Response in kidney health for Adults with type 2 diabetes

Renalytix has announced new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and improvements in kidney health in adults with type 2 diabetes. The data from an international study of 1,100 individuals with diabetic kidney disease (DKD) in the CANagliflozin Cardiovascular Assessment Study (CANVAS), was presented at the American Diabetes Association 81st Scientific Sessions […]

June 25, 2021
BioUtah News Funding
Webinar: New Non-dilutive Funding Resource for BioUtah Members

BioUtah has contracted with G2G, Washington DC’s premier consulting firm for non-dilutive funding, to receive a detailed monthly report on the funding landscape.

June 25, 2021
Policy News
Phoenix PharmaLabs Raises More than $1 Million for Continued Development of Non-Addictive Opioids

Phoenix PharmaLabs, Inc. has completed a second successful round of financing raising $1.07 million via the Netcapital equity funding portal to continue development of two non-addictive opioids to treat acute and chronic pain. “More than a thousand investors, many of whom invested in our previous funding, participated in this offering, indicating to us they did […]

June 25, 2021
BioUtah News Utah's Life Sciences Companies
Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test

Co-Diagnostics has obtained regulatory authorization to be sold as an in vitro diagnostic (“IVD”) for the diagnosis of COVID-19 in markets that accept CE markings. The Co-Diagnostics Logix Smart DS test kit detects the presence of certain genes of the COVID-19 virus directly from human saliva samples while eliminating RNA extraction of the samples. Eliminating […]

June 25, 2021
BioUtah News Utah's Life Sciences Companies
Turner Innovations Awarded STTR Phase 1 Contract from US Air Force

Turner Imaging Systems has won a small Business Technology Transfer (STTR) Phase I contract from the U.S. Air Force. Turner will use the non-dilutive funds to develop a next generation compact, highly portable, battery-powered full-body fluoroscopic X-ray (Smart-C) to help Special Operations Surgical Teams, Army Forward Surgical Teams (FSTs), and Navy Fleet Surgical Teams, save […]

June 25, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Utah Life Sciences Companies Tout BioHive at Arab Health Trade Show

Organized by World Trade Center Utah and the Governor’s Office of Economic Development (GOED), eight Utah life sciences companies recently represented the state and our industry in Dubai, as part of the Arab Health trade show. The delegation exhibited in a booth showcasing the companies and BioHive. Quansys Biosciences, Turner Imaging Solutions and Zehn-X LLC, […]

June 25, 2021
BioUtah News Utah's Life Sciences Companies
Tula Health Raises $24.1 Million, Valuation Rises to $187 Million

Tula Health recently raised $24.1 million in debt and equity financing from two venture firms – Springtide Ventures, a health tech venture firm based in Utah and Boston, and Sandbox Capital Advisors based in Salt Lake City. The company creates behavioral change guidance via on-call support, and supporting hardware and software to help their customers […]

June 25, 2021
BioUtah News Utah's Life Sciences Companies
nView s1 Reaches its 50th Surgery, Gets Navigation Capability

The nView s1, nView medical’s breakthrough imaging system, reached its 50th surgery. Twelve surgeons across three leading pediatric hospitals have used nView’s insta-3D™ technology on procedures ranging from spinal deformity corrections, to discectomies, periacetabular osteotomies and extremity procedures. nView medical CEO, Cristian Atria, said, “To celebrate the 50th surgery milestone we gave the nView s1 […]

June 25, 2021
BioUtah News Utah's Life Sciences Companies
Launch of Xenter Therapeutics

Following the close of $12M in Series A funding, Xenter, Inc., the world’s first start-up Device-Data-Drug healthcare technologies company, announced the launch of the Xenter Therapeutics business unit. Xenter Therapeutics will lead the therapeutic drug element of Xenter’s mission and vision and is headed by President and Xenter board member David J. Bearss, PhD, a biotech […]

June 18, 2021
BioUtah News Utah's Life Sciences Companies
Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology

Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer’s re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact’s University Venture Fund II. The funding will further expand programs on the Blackrock platform, including clinical studies […]

June 18, 2021
Policy News
Biden Administration Recommends Policy Changes to Secure U.S. Pharmaceutical Supply Chain

In last week’s BioUtah News and Events, we highlighted the Biden Administration’s formation of a task force to address a range of supply chain issues. This week, we share the findings of the administration’s 100-day assessment of critical supply chains, undertaken pursuant to President Biden’s February 2021 “America’s Supply Chains” executive order addressing supply chain […]

June 18, 2021
BioUtah News State News Utah's Life Sciences Companies
ARUP Celebrates Opening of a New State-of-the-Art Laboratory Facility in Salt Lake City

Founded in 1984, ARUP Laboratories, one of the nation’s largest reference laboratories, on Tuesday held a ribbon cutting ceremony to officially open its new four-story, 220,000-square-foot laboratory facility located in University of Utah Research Park. The newly constructed facility is the crown jewel of eight properties ARUP now owns and operates as Research Park’s largest […]

June 11, 2021
Policy News
Elute Receives FDA Authorization For Its First Clinical Trial Using Antibiotic Eluting Bone Void Filler

Elute has received an Investigational Device Exemption (IDE) authorization from the FDA to use its EP Granules with TobramycinTM in a pivotal clinical trial. This IDE investigates the use of a resorbable bone void filler that delivers a broad-spectrum antibiotic in the surgical treatment of bone infections following hip or knee replacements. This is the […]

June 11, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Renalytix Announces Leadership Additions for Expanding KidneyIntelX Deployment

RenalytixAI has announced a series of key hires to drive its commercialization strategy in the U.S. market in light of the recently announced Federal Government General Service Administration payment contract and additional large healthcare system partnerships. The combined background and experience of the new leadership team is expected to drive adoption of the KidneyIntelX testing […]

June 11, 2021
BioUtah News Utah's Life Sciences Companies
How St. George Became the Epicenter for a Major Global Genetics Study

The St. George Chamber of Commerce recently held a special luncheon with a presentation by Travis Sheffield, operations director for Intermountain Precision Genomics on “How St. George Became the Epicenter for a Major Global Genetics Study”. Sheffield, who is leading the HerediGene Population Study throughout Utah, Idaho, and soon in Nevada, presented the ins and […]

June 11, 2021
BioUtah News Industry News Life Sciences Industry News Utah's Life Sciences Companies
Altitude Lab Launches Investor Coalition to Fund and Mentor Healthcare Startups in Utah

On June 8, Altitude Lab has announced the launch of its Investor Coalition, a partnered network of leading healthcare venture capitalists to fund, mentor, and provide resources for Altitude-incubated startups. Together, the investor coalition aims to collectively invest $50 million in Altitude’s startups over the next three years, specifically supporting diverse and underrepresented founders. In […]

June 11, 2021
Policy News
Senate Passes Endless Frontiers Act to Boost U.S. Innovation

On Tuesday, the U.S. Senate passed the Endless Frontier Act to boost U.S. innovation and out-compete China. The bill passed the Senate by a vote of 68-32. The bill would provide $120 billion to the NSF, DOE and NASA to support research and develoopment in key technology areas critical to our national security, including biotechnology […]

June 9, 2021
Press Releases
BioUtah Statement on Launch of Altitude Lab’s Investor Coalition to Fund and Mentor Utah’s Life Sciences Startups

Salt Lake City – BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences startups in Utah. BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences […]

June 4, 2021
BioUtah News Industry News Utah's Life Sciences Companies
Scientia Raises $50M to Develop Devices for Stroke, Cancer Treatment

Scientia announced it has raised $50M in growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm. The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology. “We are excited […]

June 4, 2021
BioUtah News Economic Developments State News
Utah #1 For Best State Economic Outlook…Again

Utah has done it again! The 2021 “Rich States, Poor States” report recently released by the American Legislative Exchange Council (ALEC) ranks Utah as the state with the strongest economic outlook in the nation. Utah has held this first place designation for the past 14 years. View state-by-state data HERE. To determine its rankings, the […]

June 4, 2021
BioUtah News Industry News Utah's Life Sciences Companies
Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care

RenalytixA has announced results from a new utility study. The study confirms the importance of risk assessment testing in addressing treatment ambiguity in the early stages of diabetic kidney disease (DKD) and improving patient engagement and adherence – two major barriers to slowing or preventing DKD progression and preserving kidney health. In clinical studies, KidneyIntelX […]

June 4, 2021
BioUtah News
Known Medicine Shows Its BioHive Pride

Known Medicine is creating the world’s largest purpose-built 3D cell culture data set to predict the best drug for every cancer patient and create the best drug for every cancer. From patient tumor samples the company generates hundreds of micro-tumors on our proprietary platform and treat them with an extensive panel of drugs or drug […]

May 28, 2021
Policy News
House Democrats Urge HHS Secretary to Restore FDA Authority of COVID-19 Lab Developed Tests

Last August.under the Trump Administration, HHS announced that FDA would not have premarket review authority and oversight over laboratory developed tests (LDTs), including for COVID-19 tests and EUAs. Recently, House Energy and Commerce Committee Democrats sent a letter to HHS Secretary Becearra uring that he reverse the decision of the previous administration and reinstate FDA […]

May 28, 2021
BioUtah News Industry News Life Sciences Industry News
Turner Imaging Systems Receives CE Mark for Smart-C ® Mini C-Arm Portable Fluoroscopy X-Ray Imaging Device

Turner Imaging Systems has received its CE Mark for its Smart-C ® Mini C-Arm portable fluoroscopy x-ray imaging device. This will allow the Smart-C, the world’s first highly portable mini c-arm, to be distributed throughout the EU countries as well as the UK. “Securing the CE Mark is a critical regulatory milestone and major step […]

May 28, 2021
BioUtah News
Foldax Announces Successful First Human Use of Tria Biopolymer Mitral Heart Valve

Foldax has announced that it has successfully performed the first-in-man Tria Mitral Valve implant. This is another milestone for the Tria LifePolymer valve platform. Strategically, the mitral valve addresses an unmet global need for a more durable mitral valve that doesn’t require lifetime anticoagulants. This is especially important in the many areas where rheumatic fever […]

May 28, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Xenter, Inc. Continues Rapid Expansion with Appointment of Scott Heuler, SVP of Global Sales and Marketing, and Gary Baldwin as CTO

On the heels of last week’s announcement of the closing of its $12M Series A offering, Xenter, Inc. has announced the appointment of Scott Heuler as Senior Vice President of Global Sales & Marketing and Gary Baldwin as Chief Technology Officer in its Hospital Technologies business unit. Xenter is innovating new wireless technologies and techniques for […]

May 28, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Transit Scientific’s XO Score Scoring Sheath Platform Wins Medical Design Award

Transit Scientific”s XO Score Scoring Sheath Platform has been named a winner in the 2021 Medical Design Excellence Awards (MDEA). The MDEA is a premier design competition in the medtech industry, recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. Recently, the company received European CE Mark […]

May 25, 2021
Policy News
Letter to Utah Congressional Delegation RE: H.R. 3, The Lower Drug Costs Now Act

Today, BioUtah, in conjunction with Centro Civico Mexicano, First Step House, International Cancer Advocacy Network, Mental Healthy FIT, Northern Utah Coalition, and Patel Family Investments, sent a letter to Utah’s congressional delegation expressing concern with the reintroduction of H.R. 3, The Lower Drug Costs Now Act. In the letter, the coalition states its concern about […]

May 20, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Transit Scientific’s Cutting-Edge Scoring Sheath Platform Earns CE Mark Approval

Transit Scientific has announced that its XO Score® Scoring Sheath Platform has received CE Mark clearance in the European Union for treatment of peripheral artery disease and end stage renal disease. Last year, the company announced FDA clearance for the device. We’ve been thrilled to see the effective low-pressure dilatation and luminal gain achieved using our […]